COMP Minutes 15-17 May 2023
Cantargia receives positive opinion from EMA (COMP) - Nordic Life Science – the leading Nordic life science news service
EU Medicines Agency on X: "#EMA supports #RareDiseaseDay every day! Our Committee for Orphan Medicinal Products is the only committee fully dedicated to medicines for rare diseases. #ShowYourRare https://t.co/uNumz8tDDX https://t.co/heMlVfyYnm" / X
Une nouvelle présidente pour le COMP
EMA Committee for Orphan Medicinal Products (COMP) released its 2020 Work Plan
COMP Monthly Report from 10-11 April 2017 meeting
COMP Oral Explanation - EMA Solutions
Présentation PowerPoint
Ema services
Paratek Pharmaceuticals Inc.: European Medicines Agency COMP Recommends Positive Opinion on Orphan Medicinal Product Designation for NUZYRA® (omadacycline) for Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease - MoneyController (ID 1462605)
Amsterdam Siège de l'EMA Agence européenne des médicaments Amsterdam Photo Stock - Alamy
Engaging with the European Medicines Agency - EURORDIS Open Academy
Presentation - Centralised procedure at the European Medicines Agency
Home
With Post-Brexit Move to Amsterdam Complete, EMA Renews Rare Disease Focus
Public summary of opinion on orphan designation Cisplatin for the treatment of malignant mesothelioma
Participation des patients dans les comités réglementaires de l'EMA - EUPATI Toolbox
eric-ragazzini-ema-entrange - Entrange Music Actuelle
Fierce competition to host European Medicines Agency
OIFE at EMA Meeting on orphan drugs - OIFE - Osteogenesis Imperfecta Federation Europe
Ema delay (Bretagne) - Audiofanzine
6. How the EMA works with Healthcare Professionals - YouTube
Committee for Orphan Medicinal Products (COMP) elects new chair | European Medicines Agency
European Medicines Agency International Comp. Interior - Brick Visual
Dravet Europe | Election of Julian Isla as member of the European Orphan Drug Committee
Calaméo - 14- Les Procédures Réglementaires Européennes, Un Atout Pour La Mise Sur Le Marché Des médicamentss Orphelins ?
